Found: 9
Select item for more details and to access through your institution.
Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42458-1
- By:
- Publication type:
- Article
Author Correction: Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.
- Published in:
- Nature Communications, 2017, v. 8, n. 6, p. 1, doi. 10.1038/ncomms15772
- By:
- Publication type:
- Article
Glucocorticoid receptor signalling activates YAP in breast cancer.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 14073, doi. 10.1038/ncomms14073
- By:
- Publication type:
- Article
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast.
- Published in:
- EMBO Molecular Medicine, 2014, v. 6, n. 5, p. 702, doi. 10.1002/emmm.201470050
- By:
- Publication type:
- Article
Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-09152-7
- By:
- Publication type:
- Article
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast.
- Published in:
- EMBO Molecular Medicine, 2014, v. 6, n. 1, p. 99, doi. 10.1002/emmm.201302909
- By:
- Publication type:
- Article
Oncogenic Hijacking of the PIN1 Signaling Network.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00094
- By:
- Publication type:
- Article
Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3869, doi. 10.3390/cancers12123869
- By:
- Publication type:
- Article